29.40 
0.24(0.82%) Jun 18, 4:00PM EDT|After Hours
:
29.34 0.06 (0.20%) Jun 18, 7:16PM EDT
| Prev Close: | 29.16 |
|---|
| Open: | 29.13 |
|---|
| Bid: | 28.30 x 100 |
|---|
| Ask: | 29.34 x 300 |
|---|
| 1y Target Est: | 31.07 |
|---|
| Beta: | 0.74 |
|---|
| Next Earnings Date: | 29-Jul-13 |
|---|
| Day's Range: | 29.03 - 29.45 |
|---|
| 52wk Range: | 22.00 - 31.15 |
|---|
| Volume: | 160,346,473 |
|---|
| Avg Vol (3m): | 46,390,600 |
|---|
| Market Cap: | 208.54B |
|---|
| P/E (ttm): | 14.07 |
|---|
| EPS (ttm): | 2.09 |
|---|
| Div & Yield: | 0.96 (3.30%) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Final Glance: Pharmaceuticals companiesAP(Tue, Jun 18)
- Almirall CEO Eyes $11.6 Billion COPD Market Smokers Fuelat Bloomberg(Tue, Jun 18)
- Zoetis Exchange Offer Updateat Seeking Alpha(Tue, Jun 18)
- "Pay-For Delay" Was Fun While It Lastedat Motley Fool(Tue, Jun 18)
- Ariad's Iclusig in GIST Phase II StudyZacks(Tue, Jun 18)
- What Do These Factors Suggest About Elan Stock?at Wall St. Cheat Sheet(Tue, Jun 18)
- Midday Glance: Pharmaceuticals companiesAP(Tue, Jun 18)
- Top Treatments for High Cholesterolat Motley Fool(Tue, Jun 18)
- The NIH Aims To Develop Drugs That Big Pharma Discardedat Forbes(Tue, Jun 18)
- Early Glance: Pharmaceuticals companiesAP(Tue, Jun 18)
- Supreme Court Permits Antitrust Scrutiny Of Pharma Settlementsat Forbes(Tue, Jun 18)
- Big Pharma's Intellectual Property Bluesat Motley Fool(Tue, Jun 18)
- Court appoints lead plaintiff in shareholder lawsuit against SACReuters(Mon, Jun 17)
- Abbott Loves Abbott Laboratories Stockat Motley Fool(Mon, Jun 17)
- Pfizer Sues to Block Generic AzaSite Sales and 2 More Heavily Traded Stocks to Followat Wall St. Cheat Sheet(Mon, Jun 17)
Key Statistics
| Forward P/E (1 yr): | 12.56 |
|---|
| P/S (ttm): | 3.59 |
|---|
| Ex-Dividend Date: | 08-May-13 |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 2.21 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 0.57 |
|---|
| Mean Recommendation*: | 2.2 |
|---|
| PEG Ratio (5 yr expected): | 4.82 |
|---|
Business Summary
Pfizer Inc., a biopharmaceutical company, discovers, develops, manufactures, and sells medicines for people and animals worldwide. Its Primary Care segment offers human prescription pharmaceutical products primarily prescribed by primary-care phys...
View More